Comparison of Inpatient Glycemic Control by Continuous Glucose Monitoring (CGM) and Capillary Point-Of-Care (POC) Testing in General Medicine Patients With Type 2 Diabetes Treated With Basal Bolus Insulin Regimen

被引：0
|
作者：
Gomez, Ana M.
Umpierrez, Guillermo E.
Aschner, Pablo
Herrera, Felipe
Rubio, Claudia P.
Manoz, Oscar
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
898-P
引用
收藏
页码：A227 / A227
页数：1
相关论文
共 50 条
  • [41] Erratum to: Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
    Mihoko Matsumura
    Yuki Nakatani
    Seiichi Tanka
    Chie Aoki
    Masaaki Sagara
    Kazunori Yanagi
    Kunihiro Suzuki
    Yoshimasa Aso
    Diabetes Therapy, 2017, 8 : 1437 - 1437
  • [42] Addition of Canagliflozin to Insulin Improves Glycemic Control and Reduces Insulin Dose in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring
    Torimoto, Keiichi
    Okada, Yosuke
    Sato, Yasunori
    Tanaka, Yoshiya
    DIABETES, 2019, 68
  • [43] The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737
    Bailey, Ryan
    Calhoun, Peter
    Beck, Roy W.
    Bergenstal, Richard M.
    Aleppo, Grazia
    DIABETES CARE, 2022, 45 (04) : E85 - E86
  • [44] Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: An open label, prospective, multicenter trial in Japan
    Ogawa, Wataru
    Hirota, Yushi
    Osonoi, Takeshi
    Tosaki, Takahiro
    Kato, Yoshiro
    Utsunomiya, Kazunori
    Nishimura, Rimei
    Nakamura, Jiro
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (01) : 82 - 90
  • [45] Effect of Glycemic Control on Chylomicron Metabolism and Correlation between Postprandial Metabolism of Plasma Glucose and Chylomicron in Patients with Type 2 Diabetes Treated with Basal-bolus Insulin Therapy with or without Vildagliptin
    Okajima, Fumitaka
    Emoto, Naoya
    Kato, Katsuhito
    Sugihara, Hitoshi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (02) : 157 - 168
  • [46] Effect of tirzepatide versus insulin degludec on glycaemic control captured with continuous glucose monitoring in patients with type 2 diabetes (SURPASS-3 CGM)
    Battelino, T.
    Bergenstal, R.
    Rodriguez, A.
    Lando, L. Fernandez
    Bray, R.
    Tong, Z.
    Brown, K.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 244 - 244
  • [47] A Crossover Comparison of Glycemic Variations in Japanese Patients with Type 1 Diabetes Receiving Insulin Glargine Versus Insulin Detemir Twice Daily Using Continuous Glucose Monitoring (CGM): J COLLECTION (Jikei COmparison of Lantus and LEvemir with Cgm for Thinking Insulin OptimizatioN)
    Tsujino, Daisuke
    Nishimura, Rimei
    Morimoto, Aya
    Tajima, Naoko
    Utsunomiya, Kazunori
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (07) : 596 - 601
  • [48] The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study
    Bosi, E.
    Gregori, G.
    Cruciani, C.
    Irace, C.
    Pozzilli, P.
    Buzzetti, R.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 183
  • [49] IMPROVING GLYCEMIC CONTROL FOR PATIENTS WITH POORLY-CONTROLLED TYPE 2 DIABETES MELLITUS WITH POINT-OF-CARE HEMOGLOBIN A1C TESTING
    Hashemi, Alexandra
    Howlette, Travis
    Ezratty, Charlotte
    Small, Katherine
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S662 - S663
  • [50] Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes
    Kennedy, L
    Herman, WH
    Strange, P
    Harris, A
    DIABETES CARE, 2006, 29 (01) : 1 - 8
12345